Loading stock data…
Veeva Systems Inc. (VEEV)
$176.22+4.86 (+2.84%)
Market ClosedLast close Jun 29
Veeva Systems Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Veeva Systems Inc. in the Healthcare sector is trading at $176.22 with a market capitalization of $25.9B. Wall Street consensus targets $244.59 (27 analysts), implying a +38.8% move over the next 12 months. The stock is currently near its 52-week low of $148.05, remaining 17.9% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +38.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | $759.04M↓ | $789.08M↓ | $811.24M↓ | $835.95M↓ | $882.95M |
| Gross Profit | $585.22M↓ | $593.83M↓ | $611.77M↓ | $622.47M↓ | $662.02M |
| Operating Income | $233.73M↑ | $195.91M↓ | $240.85M↓ | $245.88M↓ | $273.11M |
| Net Income | $228.19M↑ | $200.31M↓ | $236.20M↓ | $244.20M↓ | $260.94M |
Peer Comparison
JNJUNHPFE
Fundamentals
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pha...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$25.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
28.24
Beta
Defensive asset. Lower volatility than the S&P 500.
0.95
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.89%
Volume
Today's trading volume
2.72M
Recent News
Veeva Acquires Copli & Launches Falcon MLR for Faster Content Reviews
VEEV expands its AI push with Copli acquisition and Falcon MLR launch, aiming to speed life sciences content reviews and boost Commercial Cloud.
Veeva Systems Inc. (VEEV) Acquires Copli and Launches Veeva Falcon MLR
Veeva Systems Inc. (NYSE:VEEV) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds. On June 23, Veeva Systems Inc. (NYSE:VEEV) announced that it acquired Copli and launched Veeva Falcon MLR. It made the agentic medical, legal, and regulatory content-review platform available immediately. The firm said Veeva Falcon MLR automates […]
Veeva Systems (VEEV) Stock After Recent Gains Is The Valuation Now Attractive
If you are wondering whether Veeva Systems stock offers good value at its current price, it can help to step back from the headlines and look at how different valuation methods compare. The stock last closed at US$171.36, with recent moves including an 11.8% gain over the past week and an 8.1% gain over the past month. Year to date the price is down 21.9% and the 1 year return is down 39.5%. These mixed returns sit against a backdrop where investors are paying closer attention to Veeva...
Why Veeva Systems (VEEV) Is Up 11.8% After Expanding Quality Cloud And Advancing AI Strategy
Earlier this week, Veeva Systems expanded its Quality Cloud with the launch of Veeva EHS and advanced its AI transition through acquisitions like Copli, while reporting double-digit revenue growth and raising its full-year outlook. Together, these moves deepen Veeva’s role in life sciences workflows by integrating AI-driven automation across compliance, safety, and content review, potentially reshaping how customers manage risk and regulatory complexity. We’ll now examine how the launch of...
Veeva Expands Quality Cloud With New EHS Risk Management Solution
VEEV's Veeva EHS expands Quality Cloud with automated risk, compliance and safety workflows, aiming to replace legacy systems with a unified platform.